Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…
This bill amends the Controlled Substances Act to regulate tableting and encapsulating machines and specified "critical parts." It requires serialization, registration, recordkeeping, reporting, and a National Pill Press Registry maintained by the Attorney General. The Attorney General is authorized to issue regulations, inspect registrants, assess fees, and deny, suspend, or revoke registrations.
Scope of AG regulatory power versus need for precise limits
Relative to its intended legislative type, this bill establishes a detailed substantive regulatory framework that meaningfully changes legal obligations and enforcement for tableting/encapsulating machines and specified parts, and it reasonably delegates implementation specifics to the Attorney General while integrating into existing Controlled Substances Act structures.
This bill amends the Controlled Substances Act to regulate tableting and encapsulating machines and specified "critical parts." It requires serialization, registration, recordkeeping, reporting, and a National Pill Press Registry maintained by the Attorney General.
The Attorney General is authorized to issue regulations, inspect registrants, assess fees, and deny, suspend, or revoke registrations.
The bill also creates new offenses and penalties for violating serialization, reporting, and registration requirements, with staggered effective dates and limited affirmative defenses for pre-existing owners.
Moderate chance: law‑enforcement framing helps, but regulatory burden, administrative costs, and industry resistance reduce odds absent compromise or attachment.
Relative to its intended legislative type, this bill establishes a detailed substantive regulatory framework that meaningfully changes legal obligations and enforcement for tableting/encapsulating machines and specified parts, and it reasonably delegates implementation specifics to the Attorney General while integrating into existing Controlled Substances Act structures.
Scope of AG regulatory power versus need for precise limits
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope of AG regulatory power versus need for precise limits
Generally supportive as a practical law-enforcement and public-health tool to curb illicit pill production and fentanyl deaths.
Sees serialization and registry as targeted measures to disrupt illegal pill presses if paired with treatment and prevention funding.
Concerned about overcriminalization of small legitimate businesses and privacy on the registry.
Views the bill as a reasonable, enforceable step to disrupt illicit opioid production if implemented with clear rules and proportionality.
Likes measurable requirements — serialization, registration, records — but worries about administrative burden and regulatory clarity.
Will seek cost estimates, phased implementation, and protections for legitimate industry and research.
Skeptical due to expansion of federal regulatory power and new registration burdens.
While endorsing efforts to stop illegal fentanyl production, views the bill as federal overreach that may harm manufacturers, commerce, and property rights.
Worried about needless bureaucracy, fees, and potential misuse of a national registry.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderate chance: law‑enforcement framing helps, but regulatory burden, administrative costs, and industry resistance reduce odds absent compromise or attachment.
The bill has not accumulated any surfaced votes yet.
Scope of AG regulatory power versus need for precise limits
Moderate chance: law‑enforcement framing helps, but regulatory burden, administrative costs, and industry resistance reduce odds absent com…
Relative to its intended legislative type, this bill establishes a detailed substantive regulatory framework that meaningfully changes legal obligations and enforcement for tableting/encapsulating machines and specified…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.